Search research articles
Contact Us
Filters
Showing results (221-230 of 371) with videos related to
Page
of 38
Sort By:
RMD Open
|
January 8, 2026
Effects of upadacitinib or adalimumab on pain in rheumatoid arthritis and psoriatic arthritis: results from randomised phase 3 studies
Peter C Taylor, Arthur Kavanaugh, Louis Bessette, et al.
Arthritis and Rheumatism
|
July 9, 2003
Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy
Jacques-Eric Gottenberg, Florence Merle-Vincent, Fabrice Bentaberry, et al.
Drugs - Real World Outcomes
|
January 17, 2025
Correction: Real-World Evidence of Clinical Outcomes of the Use of the Adalimumab Biosimilar SB5 in Rheumatic and Gastrointestinal Immune-Mediated Inflammatory Diseases: 12-Month Data from the PERFUSE Study
Bruno Fautrel, Yoram Bouhnik, Carine Salliot, et al.
Drugs - Real World Outcomes
|
October 9, 2024
Real-World Evidence of Clinical Outcomes of the Use of the Adalimumab Biosimilar SB5 in Rheumatic and Gastrointestinal Immune-Mediated Inflammatory Diseases: 12-Month Data from the PERFUSE Study
Bruno Fautrel, Yoram Bouhnik, Carine Salliot, et al.
Rheumatology International
|
April 10, 2024
Disease activity and widespread pain are main contributors to patient-reported global health in axial spondyloarthritis: an analysis of 6064 patients
Juliette Drouet, Clementina López-Medina, Benjamin Granger, et al.
Rheumatology (Oxford, England)
|
November 17, 2011
Assessment of work instability in spondyloarthritis: a cross-sectional study using the ankylosing spondylitis work instability scale
Isabelle Fabreguet, Eugénie Koumakis, Vincent Burki, et al.
Health and Quality of Life Outcomes
|
July 8, 2015
Relationship between optimism and quality of life in patients with two chronic rheumatic diseases: axial spondyloarthritis and chronic low back pain: a cross sectional study of 288 patients
Sarah Kreis, Anna Molto, Florian Bailly, et al.
Joint Bone Spine
|
November 6, 2021
Fluctuation of pain is frequent in rheumatoid arthritis and axial spondyloarthritis: A 12 weeks prospective study of 165 patients
Juliette Drouet, Laure Gossec, Charlotte Jacquemin, et al.
Rheumatology (Oxford, England)
|
August 3, 2022
JAK inhibitors in difficult-to-treat adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis
Louise Gillard, Jacques Pouchot, Fleur Cohen-Aubart, et al.
Journal of Crohn'S & Colitis
|
May 8, 2026
Safety of advanced therapies during pregnancy in women with immune-mediated inflammatory diseases: a systematic review and meta-analysis
Ophelie Pingeon, Nathan Grellier, Bénédicte Coulm, et al.
Page
of 38
Search research articles
Search
Showing results (221-230 of 371) with videos related to
Sort By:
Page
of 38
RMD Open
|
January 8, 2026
Effects of upadacitinib or adalimumab on pain in rheumatoid arthritis and psoriatic arthritis: results from randomised phase 3 studies
Peter C Taylor, Arthur Kavanaugh, Louis Bessette, et al.
Arthritis and Rheumatism
|
July 9, 2003
Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy
Jacques-Eric Gottenberg, Florence Merle-Vincent, Fabrice Bentaberry, et al.
Drugs - Real World Outcomes
|
January 17, 2025
Correction: Real-World Evidence of Clinical Outcomes of the Use of the Adalimumab Biosimilar SB5 in Rheumatic and Gastrointestinal Immune-Mediated Inflammatory Diseases: 12-Month Data from the PERFUSE Study
Bruno Fautrel, Yoram Bouhnik, Carine Salliot, et al.
Drugs - Real World Outcomes
|
October 9, 2024
Real-World Evidence of Clinical Outcomes of the Use of the Adalimumab Biosimilar SB5 in Rheumatic and Gastrointestinal Immune-Mediated Inflammatory Diseases: 12-Month Data from the PERFUSE Study
Bruno Fautrel, Yoram Bouhnik, Carine Salliot, et al.
Rheumatology International
|
April 10, 2024
Disease activity and widespread pain are main contributors to patient-reported global health in axial spondyloarthritis: an analysis of 6064 patients
Juliette Drouet, Clementina López-Medina, Benjamin Granger, et al.
Rheumatology (Oxford, England)
|
November 17, 2011
Assessment of work instability in spondyloarthritis: a cross-sectional study using the ankylosing spondylitis work instability scale
Isabelle Fabreguet, Eugénie Koumakis, Vincent Burki, et al.
Health and Quality of Life Outcomes
|
July 8, 2015
Relationship between optimism and quality of life in patients with two chronic rheumatic diseases: axial spondyloarthritis and chronic low back pain: a cross sectional study of 288 patients
Sarah Kreis, Anna Molto, Florian Bailly, et al.
Joint Bone Spine
|
November 6, 2021
Fluctuation of pain is frequent in rheumatoid arthritis and axial spondyloarthritis: A 12 weeks prospective study of 165 patients
Juliette Drouet, Laure Gossec, Charlotte Jacquemin, et al.
Rheumatology (Oxford, England)
|
August 3, 2022
JAK inhibitors in difficult-to-treat adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis
Louise Gillard, Jacques Pouchot, Fleur Cohen-Aubart, et al.
Journal of Crohn'S & Colitis
|
May 8, 2026
Safety of advanced therapies during pregnancy in women with immune-mediated inflammatory diseases: a systematic review and meta-analysis
Ophelie Pingeon, Nathan Grellier, Bénédicte Coulm, et al.
Page
of 38